# Thiogenesis Therapeutics , Corp .: Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis

> Thiogenesis Therapeutics announced FDA clearance of an Investigational New Drug application for a treatment of nephropathic cystinosis. The text is only a headline.

- Date: 2026-10-22 · published 2026-10-22T12:00:00.000Z
- Category: market · region US · magnitude low
- Page: https://feedsoft.ai/events/1058-thiogenesis-therapeutics-corp-thiogenesis-announces-fda-clearance-of-ind-for
- Commodities: [Methionine](https://feedsoft.ai/c/METH.md), [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

A rare-disease drug clearance has no plausible effect on feed commodity markets.

## Sources

- finanznachrichten.de: https://www.finanznachrichten.de/nachrichten-2026-10/69905396-thiogenesis-therapeutics-corp-thiogenesis-announces-fda-clearance-of-ind-for-nephropathic-cystinosis-296.htm

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.